Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
July 23, 2024
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial
Michele Clerico, Simone Ferrero, Beatrice Alessandria, et al.
Blood
|
June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
Hemasphere
|
April 21, 2020
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
Daniela Drandi, Marion Alcantara, Ichrafe Benmaad, et al.
Blood Advances
|
April 14, 2023
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
Simone Ferrero, Daniele Grimaldi, Elena Arrigoni, et al.
Hemasphere
|
May 4, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial
Francesca Cordero, Simone Ferrero, Simone Pernice, et al.
Cancers
|
January 11, 2022
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
Gian Maria Zaccaria, Simone Ferrero, Eva Hoster, et al.
Blood Advances
|
January 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial
Simone Ragaini, Anna Galli, Elisa Genuardi, et al.
Leukemia
|
November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
Mouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.
Cancer Medicine
|
March 17, 2026
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience
Stefania Oliva, Marina Martello, Elona Saraci, et al.
Blood Advances
|
August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
James Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
July 23, 2024
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial
Michele Clerico, Simone Ferrero, Beatrice Alessandria, et al.
Blood
|
June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
Hemasphere
|
April 21, 2020
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
Daniela Drandi, Marion Alcantara, Ichrafe Benmaad, et al.
Blood Advances
|
April 14, 2023
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
Simone Ferrero, Daniele Grimaldi, Elena Arrigoni, et al.
Hemasphere
|
May 4, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial
Francesca Cordero, Simone Ferrero, Simone Pernice, et al.
Cancers
|
January 11, 2022
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
Gian Maria Zaccaria, Simone Ferrero, Eva Hoster, et al.
Blood Advances
|
January 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial
Simone Ragaini, Anna Galli, Elisa Genuardi, et al.
Leukemia
|
November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
Mouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.
Cancer Medicine
|
March 17, 2026
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience
Stefania Oliva, Marina Martello, Elona Saraci, et al.
Blood Advances
|
August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
James Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Page
of 5